Literature Review
All posts tagged with “Hospice Provider News | For-profit News | Earnings Reports.”
Hospices welcome VBID’s demise, but questions remain
03/07/24 at 02:00 AMHospices welcome VBID’s demise, but questions remainHospice News, by Jim Parker; 3/5/24Citing “operational challenges,” the U.S. Centers for Medicare & Medicaid Services (CMS) announced [Monday] that it would bring to a close the hospice component of the value-based insurance design (VBID) demonstration, effective Dec. 31. ... Hospice News spoke with leaders of hospice organizations, industry groups and other stakeholders to gauge providers’ perceptions of the CMS decision.
Profits at hospice firm VITAS soar by whopping nearly 88 percent in Q4
03/05/24 at 03:00 AMProfits at hospice firm VITAS soar by whopping nearly 88 percent in Q4 McKnights Home Care, by Adam Healy; 2/29/24Hospice firm VITAS, a subsidiary of Chemed, enjoyed a stellar fourth quarter as profits rose by nearly 88% to reach $63 million. It helped to buoy Chemed’s overall earnings as the parent company’s other subsidiary, plumbing subsidiary Roto-Rooter, struggled with weaker profits and sales.
Other Business Headlines of Interest
01/05/24 at 04:00 AMOther Business Headlines of Interest, updated 1/4/24 per nasdaq.com
VITAS Expects a Steady 2024 for Revenue, Growth
12/06/23 at 04:00 AMVITAS Expects a Steady 2024 for Revenue, GrowthHospice NewsDecember 4, 2023After the tumultuous years of the pandemic, VITAS Healthcare expects a stable growth trajectory heading into 2024. Florida-based VITAS is a subsidiary of Chemed Corp. Though the company has not yet released financial guidance for 2024, VITAS anticipates a “predictable” 2024 in terms of earnings and growth, executives said at Monday’s Bank of America Healthcare Conference.